Morningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure

A Rockville-based biotech firm, American Gene Technologies (AGT), has reported promising data on its gene cell therapy for HIV cure. The treatment, which involves genetically modifying a patient’s immune cells to target and eliminate HIV-infected cells, has shown significant promise in early-stage clinical trials. According to AGT, the therapy has successfully eliminated HIV-infected cells in several patients who have undergone the treatment. The therapy involves taking a patient’s immune cells.